/
Description of Business Thermo Fisher Scientific Inc. (also referred to in this document as Thermo Fisher, we, the company, or the registrant ) is the world leader in serving science. Our Mission is to enable our customers to make the world healthier, cleaner and safer.
$492.51
+$5.29 (+1.09%)
Price from 5 days ago
17.38% operating margin is respectable but not wide. ROIC at 7.90%. Suggests the business covers its cost of capital, but doesn't point to a wide moat.
Revenue grew 3.9%, steady but not accelerating. Free cash flow declined 13% despite revenue growth, conversion is weakening.
At 27x earnings, the current multiple leaves limited room for execution misses or growth deceleration. Free cash flow declined 13% versus the prior year, cash generation momentum has weakened.
27.1x earnings, 27.2x FCF. Not cheap, the quality is already reflected in the price. Upside from here requires either margin expansion or growth re-acceleration, not just continuation.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$45.20B
▲ +3.9% YoY
Net Income (TTM)
$6.85B
▲ +5.8% YoY
Op. Margin
17.46%
▲ +0.3pp YoY
ROIC
7.87%
Cash Flow & Balance Sheet
FCF (TTM)
$6.75B
▼ -13.4% YoY
Op. Cash Flow (TTM)
$8.29B
▼ -9.8% YoY
Net Debt
$42.99B
Cash & Equiv.
$3.26B
5Y CAGR: +6.7%
5Y CAGR: -1.6%
Continue Research